154 related articles for article (PubMed ID: 23280734)
1. Non-invasive prenatal testing for fetal aneuploidy: charting the course from clinical validity to clinical utility.
Hui L
Ultrasound Obstet Gynecol; 2013 Jan; 41(1):2-6. PubMed ID: 23280734
[No Abstract] [Full Text] [Related]
2. Reflex antenatal DNA screening for Down syndrome.
Wald NJ; Huttly WJ; Bestwick JP; Aquilina J; Peregrine E
Prenat Diagn; 2015 Nov; 35(11):1154. PubMed ID: 26211510
[No Abstract] [Full Text] [Related]
3. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
4. Implementation of non-invasive prenatal testing by semiconductor sequencing in a genetic laboratory.
Dheedene A; Sante T; De Smet M; Vanbellinghen JF; Grisart B; Vergult S; Janssens S; Menten B
Prenat Diagn; 2016 Aug; 36(8):699-707. PubMed ID: 27176606
[TBL] [Abstract][Full Text] [Related]
5. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method.
Ashoor G; Syngelaki A; Wang E; Struble C; Oliphant A; Song K; Nicolaides KH
Ultrasound Obstet Gynecol; 2013 Jan; 41(1):21-5. PubMed ID: 22996646
[TBL] [Abstract][Full Text] [Related]
6. DNA sequencing versus standard prenatal aneuploidy screening.
Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
[TBL] [Abstract][Full Text] [Related]
7. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
Langlois S; Duncan A; ;
J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
[TBL] [Abstract][Full Text] [Related]
8. Microarray analysis: elegant, accurate, and expensive.
Wenstrom KD
Obstet Gynecol; 2014 Aug; 124(2 Pt 1):199-201. PubMed ID: 25004356
[No Abstract] [Full Text] [Related]
9. Open source non-invasive prenatal testing platform and its performance in a public health laboratory.
Johansen P; Richter SR; Balslev-Harder M; Miltoft CB; Tabor A; Duno M; Kjaergaard S
Prenat Diagn; 2016 Jun; 36(6):530-6. PubMed ID: 27027563
[TBL] [Abstract][Full Text] [Related]
10. Detection of de novo secondary trisomy 13 due to isochromosome (13q;13q) of paternal origin in a pregnancy with fetal cystic hygroma.
Chen CP; Ko TM; Huang MC; Chern SR; Lin TW; Chang TY; Kuo YL; Chen WL; Wang W
Taiwan J Obstet Gynecol; 2015 Feb; 54(1):78-80. PubMed ID: 25675926
[No Abstract] [Full Text] [Related]
11. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
Wagner AJ; Mitchell ME; Tomita-Mitchell A
Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.
Dar P; Curnow KJ; Gross SJ; Hall MP; Stosic M; Demko Z; Zimmermann B; Hill M; Sigurjonsson S; Ryan A; Banjevic M; Kolacki PL; Koch SW; Strom CM; Rabinowitz M; Benn P
Am J Obstet Gynecol; 2014 Nov; 211(5):527.e1-527.e17. PubMed ID: 25111587
[TBL] [Abstract][Full Text] [Related]
13. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing.
Liang D; Lv W; Wang H; Xu L; Liu J; Li H; Hu L; Peng Y; Wu L
Prenat Diagn; 2013 May; 33(5):409-15. PubMed ID: 23299662
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
[TBL] [Abstract][Full Text] [Related]
16. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A
Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe.
Stumm M; Entezami M; Haug K; Blank C; Wüstemann M; Schulze B; Raabe-Meyer G; Hempel M; Schelling M; Ostermayer E; Langer-Freitag S; Burkhardt T; Zimmermann R; Schleicher T; Weil B; Schöck U; Smerdka P; Grömminger S; Kumar Y; Hofmann W
Prenat Diagn; 2014 Feb; 34(2):185-91. PubMed ID: 24222400
[TBL] [Abstract][Full Text] [Related]
18. RETIRED: Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma.
Langlois S; Brock JA;
J Obstet Gynaecol Can; 2013 Feb; 35(2):177-181. PubMed ID: 23470070
[TBL] [Abstract][Full Text] [Related]
19. Increased risk after noninvasive prenatal screening on cell-free DNA circulating in maternal blood: does a new indication for invasive prenatal diagnosis require new criteria for confirmatory cytogenetic analysis?
Grati FR; Malvestiti F; Grimi B; Liuti R; Agrati C; Gaetani E; Milani S; Martinoni L; Zanatta V; Gallazzi G; Maggi F; Simoni G
Prenat Diagn; 2015 Mar; 35(3):308-9. PubMed ID: 25754154
[No Abstract] [Full Text] [Related]
20. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.
Iwarsson E; Jacobsson B; Dagerhamn J; Davidson T; Bernabé E; Heibert Arnlind M
Acta Obstet Gynecol Scand; 2017 Jan; 96(1):7-18. PubMed ID: 27779757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
